Cargando…
Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway
Chronic hyperglycemia increases apoptosis and reduces glucose-stimulated insulin secretion. Although protective agents have been searched extensively, none has been found so far. Here we tested FLZ, a synthetic derivative of squamosamide from a Chinese herb, as a potential candidate for antiglucotox...
Autores principales: | Kong, Xiangchen, Zhang, Longmei, Hua, Xianxin, Ma, Xiaosong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488173/ https://www.ncbi.nlm.nih.gov/pubmed/26167511 http://dx.doi.org/10.1155/2015/803986 |
Ejemplares similares
-
Squamosamide Derivative FLZ Diminishes Aberrant Mitochondrial Fission by Inhibiting Dynamin-Related Protein 1
por: Yang, Hanyu, et al.
Publicado: (2021) -
Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity
por: Zhang, Dan, et al.
Publicado: (2008) -
Squamosamide Derivative FLZ Protects Retinal Pigment Epithelium Cells from Oxidative Stress through Activation of Epidermal Growth Factor Receptor (EGFR)-AKT Signaling
por: Cheng, Li-Bo, et al.
Publicado: (2014) -
The role of membrane excitability in pancreatic β-cell glucotoxicity
por: Shyr, Zeenat A., et al.
Publicado: (2019) -
The Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36
por: Yoon, Ji Sung, et al.
Publicado: (2016)